Sa1906 – Dose Escalation with Originator Infliximab is More Common Than Standard Dosing in Pediatric IBD – the Develop ExperienceAnne M. Griffiths,Johanna C. Escher,James L. Izanec, Christopher Busse,Yanli Wang,Marla DubinskyGastroenterology（2019）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
